Atomistry » Chlorine » PDB 4e0j-4e9v » 4e20
Atomistry »
  Chlorine »
    PDB 4e0j-4e9v »
      4e20 »

Chlorine in PDB 4e20: Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor

Enzymatic activity of Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor

All present enzymatic activity of Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor:
2.7.10.2;

Protein crystallography data

The structure of Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor, PDB code: 4e20 was solved by M.A.Argiriadi, R.V.Talanian, D.W.Borhani, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 38.65 / 2.60
Space group P 31 2 1
Cell size a, b, c (Å), α, β, γ (°) 67.280, 67.280, 154.912, 90.00, 90.00, 120.00
R / Rfree (%) 19.9 / 23.3

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor (pdb code 4e20). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor, PDB code: 4e20:

Chlorine binding site 1 out of 1 in 4e20

Go back to Chlorine Binding Sites List in 4e20
Chlorine binding site 1 out of 1 in the Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl1201

b:20.0
occ:1.00
CL1 A:0MY1201 0.0 20.0 1.0
C18 A:0MY1201 1.5 32.1 1.0
C17 A:0MY1201 2.5 38.3 1.0
C19 A:0MY1201 2.5 35.8 1.0
CG2 A:VAL907 3.2 29.6 1.0
C A:GLY905 3.4 41.0 1.0
O A:GLY905 3.5 41.9 1.0
N A:LYS906 3.5 36.4 1.0
N A:VAL907 3.7 29.4 1.0
CA A:LYS906 3.7 36.2 1.0
C A:LYS906 3.8 36.6 1.0
C16 A:0MY1201 3.8 34.0 1.0
C14 A:0MY1201 3.8 43.9 1.0
CE A:LYS926 3.8 28.1 1.0
N A:GLY902 4.0 38.1 1.0
CA A:GLY905 4.1 37.9 1.0
O A:GLY900 4.2 37.8 1.0
CA A:GLU901 4.2 36.0 1.0
C15 A:0MY1201 4.3 37.3 1.0
CG A:LYS926 4.3 30.1 1.0
CD A:LYS926 4.3 27.3 1.0
CB A:VAL907 4.4 29.4 1.0
NZ A:LYS926 4.4 31.4 1.0
C A:GLY900 4.4 38.0 1.0
N A:GLU901 4.4 36.6 1.0
C A:GLU901 4.5 39.7 1.0
O A:LYS906 4.5 37.7 1.0
OD1 A:ASP1037 4.5 48.4 1.0
CA A:VAL907 4.6 27.7 1.0
CA A:GLY902 4.8 38.0 1.0
N A:GLY905 4.9 39.3 1.0

Reference:

M.A.Argiriadi, E.R.Goedken, D.Banach, D.W.Borhani, A.Burchat, R.W.Dixon, D.Marcotte, G.Overmeyer, V.Pivorunas, R.Sadhukhan, S.Sousa, N.S.Moore, M.Tomlinson, J.Voss, L.Wang, N.Wishart, K.Woller, R.V.Talanian. Enabling Structure-Based Drug Design of TYK2 Through Co-Crystallization with A Stabilizing Aminoindazole Inhibitor. Bmc Struct.Biol. V. 12 22 2012.
ISSN: ESSN 1472-6807
PubMed: 22995073
DOI: 10.1186/1472-6807-12-22
Page generated: Fri Jul 11 14:35:43 2025

Last articles

Cl in 4XD1
Cl in 4XDQ
Cl in 4XD0
Cl in 4XCU
Cl in 4XCZ
Cl in 4XAD
Cl in 4XC5
Cl in 4XCV
Cl in 4XAQ
Cl in 4XC4
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy